WASHINGTON (Reuters) – U.S. Health and Human Services Secretary Xavier Becerra said on Friday the government will try to negotiate better prices for the 15 drugs targeted for Medicare price negotiations for 2027 because they are too expensive.
“The reason we’re going to negotiate for lower prices of these 15 drugs, the way we did last year for the 10 most expensive drugs, is because the facts show that not only do they work, but those drugs are too expensive and should be lowered in price,” Becerra said in an interview with CNN.
(Reporting by Doina Chiacu; editing by Christina Fincher)
